Potential roles of insulin and IGF-1 in Alzheimer's disease

被引:223
|
作者
Gasparini, L
Xu, HX
机构
[1] Nicox Res Inst, I-20091 Milan, Italy
[2] Rockefeller Univ, Fisher Ctr Res Alzheimer Dis, New York, NY 10021 USA
关键词
D O I
10.1016/S0166-2236(03)00163-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Aging is characterized by a significant decline of metabolic and hormonal functions, which often facilitates the onset of severe age-associated pathologies. One outstanding example of this is the reported association of deranged signaling by insulin and insulin-like-growth-factor 1 (IGF-1) with Alzheimer's disease (AD). Recent compelling biological data reveal effects of insulin and IGF-1 on molecular and cellular mechanisms underlying the pathology of AD. This review discusses available biological data that highlight the therapeutic potential of the insulin-IGF-1 signaling pathway in AD.
引用
收藏
页码:404 / 406
页数:3
相关论文
共 50 条
  • [41] THE ROLES OF INSULIN-LIKE GROWTH FACTOR-I (IGF-1) DURING PREGNANCY
    MORIKAWA, H
    UEDA, Y
    TAKEUCHI, M
    HORIUCHI, A
    KOBAYASHI, A
    DEGUCHI, M
    MOCHIZUKI, M
    ENDOCRINOLOGIA JAPONICA, 1987, 34 : 170 - 170
  • [42] IGF-1 LEVELS DECLINE WITH MIDDLE-AGE WHILE IGF-1 (BUT NOT INSULIN) RESPONSIVENESS IS MAINTAINED
    BOULWARE, S
    RENNERT, N
    TAMBORLANE, W
    SHERWIN, R
    DIABETES, 1993, 42 : A45 - A45
  • [43] sTREM2 and GFAP Mediated the Association of IGF-1 Signaling Biomarkers with Alzheimer's Disease Pathology
    Wang, Zhe
    Tan, Lin
    Zong, Yu
    Ma, Ya-Hui
    Wang, Zhi-Bo
    Wang, Hui-Fu
    Tan, Lan
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 92 (03) : 791 - 797
  • [44] Acute exercise increases circulating IGF-1 in Alzheimer's disease patients, but not in older adults without dementia
    Stein, Angelica Miki
    Vital da Silva, Thays Martins
    de Melo Coelho, Flavia Gomes
    Rueda, Andre Veloso
    Camarini, Rosana
    Santos Galduroz, Ruth Ferreira
    BEHAVIOURAL BRAIN RESEARCH, 2021, 396
  • [45] Neuronal IGF-1 resistance reduces Aβ accumulation and protects against premature death in a model of Alzheimer's disease
    Freude, Susanna
    Hettich, Moritz M.
    Schumann, Christina
    Stoehr, Oliver
    Koch, Linda
    Koehler, Christoph
    Udelhoven, Michael
    Leeser, Uschi
    Mueller, Marita
    Kubota, Naoto
    Kadowaki, Takashi
    Krone, Wilhelm
    Schroeder, Hannsjoerg
    Bruening, Jens C.
    Schubert, Markus
    FASEB JOURNAL, 2009, 23 (10): : 3315 - 3324
  • [46] Immunolocalization of the insulin like growth factor-1 (IGF-1) and IGF-1 receptor (IGF-1R) in the ovary of the bitch
    Cardilli, D. J.
    Oliveira, K. S.
    Joao, C. F.
    Voorwald, F. A.
    Silva, M. A. M.
    Oliveria, J. A.
    Toniollo, G. H.
    Perez-Gutierrez, J. F.
    REPRODUCTION IN DOMESTIC ANIMALS, 2012, 47 : 116 - 117
  • [47] Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors
    Bernhard, Felix P.
    Heinzel, Sebastian
    Binder, Gerhard
    Weber, Karin
    Apel, Anja
    Roeben, Benjamin
    Deuschle, Christian
    Maechtel, Mirjam
    Heger, Tanja
    Nussbaum, Susanne
    Gasser, Thomas
    Maetzler, Walter
    Berg, Daniela
    PLOS ONE, 2016, 11 (03):
  • [48] Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?
    Bassil, Fares
    Fernagut, Pierre-Olivier
    Bezard, Erwan
    Meissner, Wassilios G.
    PROGRESS IN NEUROBIOLOGY, 2014, 118 : 1 - 18
  • [49] ACTUAL AND POTENTIAL CLINICAL USES OF IGF-1
    WASS, JAH
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY, 1993, 6 (3-4) : 329 - 331
  • [50] Reduced insulin/IGF-1 signalling and human longevity
    van Heemst, D
    Beekman, M
    Mooijaart, SP
    Heijmans, BT
    Brandt, BW
    Zwaan, BJ
    Slagboom, PE
    Westendorp, RGJ
    AGING CELL, 2005, 4 (02) : 79 - 85